Sanofi (SNY) Net Income (2009 - 2026)

Sanofi has disclosed Net Income across 18 years of filings, most recently posting $2.2 billion for Q2 2026.

• In Q2 2026, Net Income fell 58.94% year-over-year to $2.2 billion; the TTM figure through Jun 2026 stood at $12.9 billion (down 22.82% YoY), while the FY2025 annual figure was $9.3 billion, down 13.76% from the prior year.
• Net Income came in at $2.2 billion for Q2 2026 at Sanofi, down from $3.3 billion in the prior quarter.
• In the past five years, Net Income ranged from a high of $14.6 billion in Q3 2025 to a low of -$7.2 billion in Q4 2025.
• Average Net Income over 5 years is $4.0 billion, with a median of $3.3 billion recorded in 2026.
• The largest YoY upside for Net Income was 186.68% in 2025 against a maximum downside of 341.13% in 2025.
• Over 5 years, Net Income stood at $9.2 billion in 2022, then grew by 5.15% to $9.7 billion in 2023, then slumped by 69.31% to $3.0 billion in 2024, then sank by 341.13% to -$7.2 billion in 2025, then surged by 130.25% to $2.2 billion in 2026.
• Per Business Quant data, the three most recent Net Income figures were $2.2 billion in Q2 2026, $3.3 billion in Q1 2026, and -$7.2 billion in Q4 2025.